drugset / Trial / NCT00842504

Alternate Day Micafungin: A PK Study in Pediatric Patients

NCT00842504

Non-randomizedSingle-groupOpen-labelBasic science

Summary

The purpose of this study is to examine the pharmacokinetics of micafungin when it is given on an every other day schedule. The study will determine if every other day micafungin will provide drug exposure equivalent to daily dosing while reducing administration costs and improving patient convenience. Fifteen patients will be enrolled on this study. Blood samples for PK measurements will be obtained for 48 hours following a single dose of micafungin (3 mg/kg).

Timeline

Start
2007-07
Primary completion
2009-12
Completion
2009-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Micafungin Peptide 3 mg/kg Intravenous